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Summary During the past few decades, an increasing number of immunosuppressive drugs
have been developed to treat autoimmune and rheumatic diseases, as well as post-transplant
patients. In parallel, the incidence of immunocompromized patients in the general population has
risen, for example, patients who are HIV positive, undergoing hemodialysis or suffering from
diabetes mellitus. In such predisposed patients, infections with organisms of even reduced
invasive potential can result in atypical invasive manifestations.
In industrialized countries, an increase in the number of human non-typhoid Salmonella
infections was observed in the 1980—1990 s [Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigs-
berger H, Drucker M, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical
presentation, bacteriology, and outcome. Clin Infect Dis 1999;28:822—7]. Beyond the main
clinical manifestation of gastroenteritis, there is an increasing prevalence of extra-intestinal
infections by this pathogen. We report a patient with acute osteomyelitis due to Salmonella
typhimurium without any previous signs of gastroenteritis.
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A 63-year-old male was referred from a district hospital with
the diagnosis of lymphoma of the right femur associated with
periosteal abscess formation (Figure 1). Painful swelling of
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doi:10.1016/j.ijid.2008.06.030the leg during the previous eight weeks. These symptoms
were accompanied by three episodes of fever up to 38.9 8C
and shivering. The patient had a medical history of arterial
hypertension, diabetes mellitus controlled by oral antidia-
betics, and pulmonary fibrosis treated with oral cortisone
(8 mg/day) and azathioprine (100 mg/day) for several years.
Deep venous thrombosis had been excluded by duplex sono-
graphy. An MRI scan showed an infiltrating intramedullary
process replacing normal bone marrow within the right
femur, compatible with lymphoma and accompanied by mas-
sive myositis. A chest X-ray suggested a polycyclic tumorous
enlargement of the left lung hilus. These symptoms had been
interpreted as a malignant lymphoma of the femur andPublished by Elsevier Ltd. All rights reserved.
Figure 1 MRI scan of the femur, showing (A) the extent of Salmonella osteomyelitis within the distal femur, and (B) periosteal and
submuscular abscess formation.
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biotic therapy with clindamycin had been started in the
referring hospital.
The patient was in a reduced physical condition, but blood
pressure, heart rate and abdomen did not show any abnorm-
alities. The right knee, calf and thigh were swollen and
tender, with elevated temperature and livid color of the
overlying skin. WBC count was 19.5  109 cells/l and C-
reactive protein was 47 mg/l (normal < 5 mg/l). Other blood
chemistry was within normal limits. Plain radiographs of the
right knee revealed no destruction of bony structures. A CT
scan of the thorax confirmed pulmonary fibrosis, but revealed
no tumorous lymph nodes. 99mTc bone scintiscan showed
accumulation of activity at the right femur and thoracic
vertebrae 7 and 8. A CT-guided biopsy of the soft tissue
process and the femur corticalis revealed non-specific myo-
sitis and acute destructive osteomyelitis without signs of
malignancy. The microbiological workup resulted in Salmo-
nella typhimurium. Sequestrotomy, lavage, local antibiotic
treatment and drainage were performed. Consequently,
local symptoms improved. However, on the fifth post-opera-
tive day, the patient developed septicemia with cardiocircu-
latory and respiratory insufficiency, to which he finally
succumbed on day nine. Autopsy revealed severe pseudo-
membranous colitis.
Discussion
Infections with non-typhoid Salmonella species are most
frequently acquired through consumption of contaminated
food, in particular uncooked eggs, poultry and meat pro-
ducts. Usually, the incubation period is 7 hours to 2 days, and
the infection presents as self-limiting gastroenteritis. Sal-monella serotypes typhimurium and enteritidis account for
83% of infections,2 leading to diarrhea, vomiting, abdominal
cramps and low-grade fever. Temperatures return to normal
within 48—72 hours and diarrhea resolves within 10 days.
Specific antibiotic treatment is not warranted, but fluid and
electrolyte replacement might be necessary in elderly
patients or those with underlying disease. Hospital admission
is required in 13—29% of cases.2,3 Less than 6% of immuno-
competent patients were reported to be bacteremic. Focal
infections of various organs occur during septicemia and can
involve almost all organ systems.
Salmonella arthritis and osteomyelitis occur with a fre-
quency of less than 1%, and clinical signs of recent gastro-
intestinal infection cannot always be seen.4—6 Clinical signs
of osteomyelitis include fever, bone pain, soft tissue swelling
and leukocytosis, and are not indicative of the causative
agent. Diaphysis and epiphysis of femur, tibia and humerus,
as well as lumbar vertebrae, represent the most affected
sites. S. typhimurium and S. enteritidis are themost common
serotypes of human non-typhoid Salmonella infections, but
recently other serotypes have been observed significantly
more frequently.7,8
Immunity to Salmonella infection requires interplay
between the innate and the adaptive immune systems.9 After
ingestion, passage of Salmonella occurs via the epithelial M
cells overlaying Peyer’s patches, invasion of enterocytes or
shuttling by cells that physiologically breach the epithelial
layer, for example, dendritic cells (DCs). The presence of
Salmonella on the basal site of enterocytes leads to the
secretion of chemokines (IL-8, MIP-3a, MIP-2 and TNF-a),
attracting cells of the innate immune system (neutrophils,
macrophages, DCs and natural killer [NK] Tcells). The expres-
sion of co-stimulatory molecules is upregulated soon after
Salmonella osteomyelitis e69infection and a myriad of cytokines are secreted (IFN-g, IL-
12, TNF-a and others). These cytokines are essential for the
recruitment and activation of cells of the adaptive immune
system, resulting in an efficient B- and T-cell response.10,11
Experiments in mice deficient in MHC class I, MHC class II or B
cells have shown that CD4+ cells have a pivotal role in
immunity to Salmonella, but CD8+ T cells and B cells play
important contributory roles.
Translocation of Salmonella from the intestinal lumen to
the submucosa, mesenteric lymph nodes and distant organs
requires disruption of the mucosal barrier and suppression
of the aforementioned host immune defense mechanisms.
In our case, the patient had been treated with steroids and
azathioprine for years, and received antacid treatment with
omeprazole, increasing his susceptibility to Salmonella infec-
tion. The effects of glucocorticoids and azathioprine on the
innate and adaptive immune response are summarized in
Table 1. Most importantly, secretion of TNF-a and IFN-g, which
is essential in the initiation of the anti-Salmonella immune
response, is significantly downregulated by glucocorticoids,
and DCs are reduced in number and show diminished allosti-
mulatory capacity.12 These mechanisms severely impede the
induction of an effective specific immune response, which isTable 1 Effects of corticosteroids and azathioprine on the
innate and adaptive immune responses
Corticosteroid-induced effects on the immune system
Dendritic cells
Inhibition of DC migration to the draining lymph node
Inhibition of DC maturation
Decrease in MHC class II expression
Decreased allostimulatory capacity
Decreased TNF-a, IFN-g, IL-6 and IL-12 secretion
Increased expression of anti-inflammatory cytokines
(e.g. IL-10)
Innate immune response
Impaired phagocytosis, degranulation and oxidative burst
of neutrophils and monocytes/macrophages (MM)
Reduced cytokine production in neutrophils and MM
Impaired formation of nitric oxide in neutrophils and MM
Defective adhesion to endothelium, extravasation and
chemotaxis of neutrophils and MM
Impaired maturation of MM
Adaptive immune response
Decreased lymphocyte proliferation and migration
Impaired delayed type hypersensitivity
Th1/Th2 dysregulation of the immune response
Decreased cytokine production (IL-2, IL-12)
Impaired cellular immune response
Mucosa-associated immune system
Decreased IgA levels
Increased bacterial translocation to mesenteric
lymph nodes
Azathioprine-induced effects on the immune system
Decreased allostimulatory capacity of DCs
Induction of T-cell anergy and/or apoptosis by interference
with CD28 signalingfurther hampered by the direct action of glucocorticoids on T
and B cells. Azathioprine contributes to the suppression of the
adaptive immune response by inducing T-cell apoptosis
through interference with the CD28 co-stimulatory signaling
cascade.13 Treatment with glucocorticoids also influences the
barrier function of the gut. The histopathology of the gut-
associated lymphatic tissue (GALT) in corticosteroid-treated
animals demonstrates changes in the dome epithelium of the
Peyer’s patches and a significantly reduced number of M
cells.14 Levels of secreted IgA are dramatically reduced,
resulting in an increase in bacterial adhesion to the mucosa
and translocation to mesenteric lymph nodes. In our patient,
pre-existing diabetes and treatment with the proton pump
inhibitor omeprazole might have acted synergistically with
immunosuppressive therapy, as both were identified as risk
factors for Salmonella infection.15,16
In immunocompromized patients, diagnosis of infections
can bedelayed because of the absence of overt clinical signs.
In our case, the presence of a hilar mass in the initial chest X-
ray had pointed the diagnosis towards a malignant lym-
phoma, rather than towards infection. Patients under
long-term treatment with thiopurines (azathioprine and 6-
mercaptopurine) are exposed to an increased risk of lym-
phoma in the context of autoimmune disease.17,18 Primary
lymphoma of the bone occurs at age 50—60 and accounts for
3—4% of all malignant bone tumors.19,20 The femur is most
commonly involved, and the main symptoms are pain, swel-
ling and pathological fracture.19,21 B symptoms are rarely
present and few patients present with symptoms of systemic
disease.19,21 Radiological finding are usually discrete with
conventional techniques and, although MRI might show
changes of intramedullary tumor infiltration, none of these
findings is pathognomonic.
In conclusion, an infectious process with atypical or com-
mensal bacteria should definitively be included in the differ-
ential diagnosis for immunocompromized patients. In the
described case, multiple risk factors for systemic infection
with food-borne pathogens were present. Early CT-guided or
open biopsy should have resulted in earlier diagnosis and
appropriate treatment.
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